FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:1320-1321 October 30, 1997 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Pui, C.-H. PubMed Citation

To the Editor: The conclusion of Pui et al. (June 19 issue)¹ that "whether the benefits of G-CSF [granulocyte colony-stimulating factor] therapy justify its use in individual cases is ultimately a matter of clinical judgment" is surprising. Their study showed that G-CSF use halved the median duration of hospital stays (from 10 days to 6 days, P = 0.011) and the incidence of documented infections (from 27 to 12, P = 0.009). Children receiving G-CSF had fewer episodes of bacteremia, disseminated fungal infections, cellulitis, central venous catheter–associated infections, otitis media, Clostridium difficile enterocolitis, and lymphadenitis. Nevertheless, the editorial in the . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.